Haoxi Health Technology Limited Statistics
Share Statistics
Haoxi Health Technology Limited has 36.24M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 36.24M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 124.63K |
FTD / Avg. Volume | 1.8% |
Short Selling Information
The latest short interest is 2.56M, so 7.06% of the outstanding shares have been sold short.
Short Interest | 2.56M |
Short % of Shares Out | 7.06% |
Short % of Float | 11.05% |
Short Ratio (days to cover) | 0.32 |
Valuation Ratios
The PE ratio is 121.53 and the forward PE ratio is null.
PE Ratio | 121.53 |
Forward PE | null |
PS Ratio | 3.24 |
Forward PS | null |
PB Ratio | 13.93 |
P/FCF Ratio | -195.5 |
PEG Ratio | n/a |
Enterprise Valuation
Haoxi Health Technology Limited has an Enterprise Value (EV) of -.
EV / Earnings | null |
EV / Sales | null |
EV / EBITDA | null |
EV / EBIT | null |
EV / FCF | null |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.11.
Current Ratio | 3.98 |
Quick Ratio | 3.98 |
Debt / Equity | 0.11 |
Total Debt / Capitalization | 9.63 |
Cash Flow / Debt | -0.62 |
Interest Coverage | 41.69 |
Financial Efficiency
Return on equity (ROE) is 0.11% and return on capital (ROIC) is 10.25%.
Return on Equity (ROE) | 0.11% |
Return on Assets (ROA) | 0.08% |
Return on Capital (ROIC) | 10.25% |
Revenue Per Employee | 1.62M |
Profits Per Employee | 43.06K |
Employee Count | 30 |
Asset Turnover | 3.13 |
Inventory Turnover | 0 |
Taxes
Income Tax | 443.58K |
Effective Tax Rate | 0.26 |
Stock Price Statistics
The stock price has increased by -99.48% in the last 52 weeks. The beta is 1.28, so Haoxi Health Technology Limited's price volatility has been higher than the market average.
Beta | 1.28 |
52-Week Price Change | -99.48% |
50-Day Moving Average | 0.19 |
200-Day Moving Average | 3.87 |
Relative Strength Index (RSI) | 35.48 |
Average Volume (20 Days) | 6.94M |
Income Statement
In the last 12 months, Haoxi Health Technology Limited had revenue of $48.52M and earned $1.29M in profits. Earnings per share was $0.04.
Revenue | 48.52M |
Gross Profit | 2.75M |
Operating Income | 1.72M |
Net Income | 1.29M |
EBITDA | 1.79M |
EBIT | 1.72M |
Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has $6.66M in cash and $1.20M in debt, giving a net cash position of $5.45M.
Cash & Cash Equivalents | 6.66M |
Total Debt | 1.20M |
Net Cash | 5.45M |
Retained Earnings | 723.21K |
Total Assets | 15.51M |
Working Capital | 11.51M |
Cash Flow
In the last 12 months, operating cash flow was -$747.58K and capital expenditures -$55.37K, giving a free cash flow of -$802.94K.
Operating Cash Flow | -747.58K |
Capital Expenditures | -55.37K |
Free Cash Flow | -802.94K |
FCF Per Share | -0.03 |
Margins
Gross margin is 5.67%, with operating and profit margins of 3.54% and 2.66%.
Gross Margin | 5.67% |
Operating Margin | 3.54% |
Pretax Margin | 3.58% |
Profit Margin | 2.66% |
EBITDA Margin | 3.68% |
EBIT Margin | 3.54% |
FCF Margin | -1.65% |
Dividends & Yields
HAO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 30.77% |
FCF Yield | -16.81% |
Analyst Forecast
Currently there are no analyst rating for HAO.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 6.08 |
Piotroski F-Score | 5 |